Photo of W. Conrad Liles, MD, PhD
Professor
Department of Medicine, Division of Allergy and Infectious Diseases
Adjunct Professor
Department of Global Health
Adjunct Professor
Department of Pathology
Adjunct Professor
Department of Pharmacology
Co-Director, Molecular Medicine and Mechanisms of Disease (M3D) Graduate Program
Co-Director, Molecular Medicine Training Program, University of Washington
Associate Chair, Department of Medicine
Related Links: 
Liles Lab

Faculty Information

Biography

Dr. Liles returned to the University of Washington in 2012 from the University of Toronto, where he was Vice-Chair and Professor of Medicine, Director of the Division of Infectious Diseases, and the Canada Research Chair in Infectious Diseases and Inflammation. In addition to his duties as Professor and Associate Chair, Dr. Liles serves as Co-Director of the Molecular Medicine Training Program at the University of Washington.

Education & Training: 
MD
University of Washington
Seattle WA
1987
PhD
University of Washington
Seattle WA
1987
Residency
Massachusetts General Hospital
Boston MA
1987-1990
Chief Residency
University of Washington Medical Center
Seattle WA
1990-1991
Fellowship in Infectious Diseases
University of Washington
Seattle WA
1991-1994
Honors: 
Elected member, Association of American Physicians (AAP)
Elected member, American Clinical and Climatological Association (ACCA)
Fellow, American College of Physicians (ACP)
Fellow, Infectious Diseases Society of America (IDSA)
Canada Research Chair in Inflammation and Infectious Diseases
2006-2012
Fialkow Scholar Award
1998
Contact
Email: 
wcliles@uw.edu
Phone: 
(206) 221-6965
Mailing Address: 

1959 NE Pacific Street, Box 356420, Seattle, WA 98195

 

Research & Clinical Interests
Research Interests: 
  • Innate immunity
  • Molecular pathogenesis of organ injury
  • Acute lung injury/ARDS
  • Acute kidney injury (AKI)
  • Endothelial cell biology
  • Sepsis
  • Malaria
  • Immunopathogenesis ofinfectious diseases
  • Phagocyte biology

 

Clinical Interests: 
  • Tropical medicine
  • Zoonoses
  • Congenital immunodeficiency disorders
  • General infectious diseases
  • Immunomodulatory therapy

 

Publications
PubMed: 
PubMed Bibliography
Publications: 

Mei, SHJ, Haitsma, JJ, Santos, CC dos, Deng, Y, Lai, PFH, Slutsky, AS, Liles WC, Stewart, DJ. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis.. Am J Respir Crit Care Med. 2010; 182(8): 1047-57.

Ricciuto, DR, Santos, CC dos, Hawkes, M, Toltl, LJ, Conroy, AL, Rajwans, N, Lafferty, EI, Cook, DJ, Fox-Robichaud, A, Kahnamoui, K, Kain, KC, Liaw, PC, Liles WC. Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis. Crit Care Med. 2011; 39(4): 702-10.

dos Santos C, Murthy S, Hu P, Shan Y, Haitsma JJ, Mei SHJ, Stewart DJ, Liles WC. Network analysis of transcriptional responses induced by mesenchymal stem cell treatment of experimental sepsis. Am J Pathol.2012; 181(5): 1681-92.